Selected references

June 10, 2008 - 7:30am

Rate This

Selected references

]]>Previous]]> | ]]>Return to main page]]> | ]]>Multiple Sclerosis]]> | ]]>Research and Treatment of Multiple Sclerosis]]>

Review Articles

Hooper K. Managing Progressive MS. New York, NY: National Multiple Sclerosis Society; 2011.

Multiple Sclerosis: Just the Facts New York, NY; National Multiple Sclerosis Society;2011.

Brod, S., Lindsey, J. W., Wolinsky, J. S. 1996. Multiple Sclerosis: Clinical Presentation, Diagnosis and Treatment. American Family Physician , 54:1301-1311.

Dinter, H., Onuffer, J., Faulds, D. and Perez H. D. 1997. Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis. Journal of Molecular Medicine, 75:95-102.

Johnson, K. P. 1997. The historical development of interferons as multiple sclerosis therapies. Journal of Molecular Medicine , 75:89-94.

Sawcer, S., Goodfellow, P. N., and Compston, A. 1997. The genetic analysis of multiple sclerosis. Trends in Genetics , 13:234-239.

Stinissen, P., Raus, J., and Zhang, J. 1997. Autoimmune Pathogenesis of Multiple Sclerosis: Role of Autoreactive T Lymphocytes and New Immunotherapeutic Strategies. Critical Reviews in Immunology , 17:33-75.

Research Papers

Arnon, R., Sela, M. and Teitelbaum, D. 1996. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. Journal of Neurology , 243(Supplement 1):S8-S13.

Jacobs, L. D., et al. 1996. Intramusculat Interferon Beta-1a for Disease Progression in Relapsing Multiple Sclerosis. Annals of Neurology , 39:285-294.

Johnson, K. P. 1996. A review of the clinical efficacy profile of copolymer 1: new U. S. phase III trial data. Journal of Neurology , 243(Supplement 1):S3-S7.

Rudick, R. A., et al. 1997. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. Neurology , 49:358-363.

Sadovnick, A. D., Ebers, G. C., Dyment, D. A., Risch, N. J., et al. 1996. Evidence for genetic basis of multiple sclerosis. The Lancet , 347:1728-1730.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.